Multi-center prospective evaluation of discharge criteria for hospitalized patients with Crimean-Congo Hemorrhagic Fever

Antiviral Research

Volumn 133, Issue , 2016, Pages 9-13

  Leblebicioglu, Hakan ^a   Sunbul, Mustafa ^a   Barut, Sener ^b   Buyuktuna, Seyit Ali ^c   Ozkurt, Zulal ^d   Yapar, Derya ^e   Yilmaz, Gurdal ^f   Guner, Rahmet ^g   But, Ayse ^h   Cicek Senturk, Gonul ⁱ   Murat, Naci ^j   Ozaras, Resat ^k   Bakir, Mehmet ^l   Baykam, Nurcan ^l   Bodur, Hurrem ^l   Bozkurt, Ilkay ^l   Koksal, Iftihar ^l   Sencan, Irfan ^l  

^a ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b GAZIOSMANPASA UNIVERSITY   (Turkey)

^c CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^d ATATURK UNIVERSITY   (Turkey)

^e HITIT UNIVERSITY   (Turkey)

^f KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^g YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^h ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

ⁱ DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^j ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^k ISTANBUL UNIVERSITY   (Turkey)

^l NONE

more..

Author keywords

Crimean Congo Hemorrhagic Fever; Discharge disposition; Reported outcomes

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CREATININE; FIBRINOGEN; HEMOGLOBIN; UREA; BIOLOGICAL MARKER;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CREATININE BLOOD LEVEL; CRIMEAN CONGO HEMORRHAGIC FEVER; CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; RELAPSE; SECONDARY INFECTION; TERTIARY CARE CENTER; THROMBOCYTE; THROMBOCYTE COUNT; UREA BLOOD LEVEL; VIRUS TRANSMISSION; AGED; CLINICAL DECISION MAKING; CLINICAL TRIAL; HEALTH SURVEY; HOSPITALIZATION; MULTICENTER STUDY; STANDARDS;

ADULT; AGED; BIOMARKERS; CLINICAL DECISION-MAKING; FEMALE; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT DISCHARGE; POPULATION SURVEILLANCE;

EID: 84979285124     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2016.07.010     Document Type: Article

References (36)

1. Akinci, E., Bodur, H., Leblebicioglu, H., Pathogenesis of crimean-congo hemorrhagic Fever. Vector Borne Zoonotic Dis. 13:7 (2013), 429–437.
2. Bente, D.A., Forrester, N.L., Watts, D.M., McAuley, A.J., Whitehouse, C.A., Bray, M., Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity. Antivir. Res. 100:1 (2013), 159–189.
3. Bodur, H., Akinci, E., Öngürü, P., Carhan, A., Uyar, Y., Tanrici, A., Cataloluk, O., Kubar, A., Detection of Crimean-Congo hemorrhagic fever virus genome in saliva and urine. Int. J. Infect. Dis. 14:3 (2010), e247–e249.
4. Bozkurt, I., Sunbul, M., Yilmaz, H., Esen, S., Leblebicioglu, H., Beeching, N.J., Direct healthcare costs for patients hospitalized with Crimean-Congo haemorrhagic fever can be predicted by a clinical illness severity scoring system. Pathog. Glob. Health 110:1 (2016), 9–13.
5. Cevik, M.A., Erbay, A., Bodur, H., Eren, S.S., Akinci, E., Sener, K., Onguru, P., Kubar, A., Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin. Infect. Dis. 45:7 (2007), E96–E100.
6. Christie, A., Davies-Wayne, G.J., Cordier-Lassalle, T., Blackley, D.J., Laney, A.S., Williams, D.E., Shinde, S.A., Badio, M., Lo, T., Mate, S.E., Ladner, J.T., Wiley, M.R., Kugelman, J.R., Palacios, G., Holbrook, M.R., Janosko, K.B., de Wit, E., van Doremalen, N., Munster, V.J., Pettitt, J., Schoepp, R.J., Verhenne, L., Evlampidou, I., Kollie, K.K., Sieh, S.B., Gasasira, A., Bolay, F., Kateh, F.N., Nyenswah, T.G., De Cock, K.M., Centers for Disease and Prevention. Possible sexual transmission of Ebola virus - Liberia, 2015. MMWR Morb. Mortal. Wkly. Rep. 64:17 (2015), 479–481.
7. Chughtai, A.A., Barnes, M., Macintyre, C.R., Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control. Epidemiol. Infect. 144:8 (2016), 1652–1660.
8. Dreshaj, S., Ahmeti, S., Ramadani, N., Dreshaj, G., Humolli, I., Dedushaj, I., Current situation of Crimean-Congo hemorrhagic fever in Southeastern Europe and neighboring countries: a public health risk for the European Union?. Travel Med. Infect. Dis. 14:2 (2016), 81–91.
9. Duh, D., Saksida, A., Petrovec, M., Ahmeti, S., Dedushaj, I., Panning, M., Drosten, C., Avsic-Zupanc, T., Viral load as predictor of crimean-congo hemorrhagic fever outcome. Emerg. Infect. Dis. 13:11 (2007), 1769–1772.
10. Ergonul, O., Battal, I., Potential sexual transmission of Crimean-Congo hemorrhagic fever infection. Jpn. J. Infect. Dis. 67:2 (2014), 137–138.
11. Ergunay, K., Tufan, Z.K., Bulut, C., Kinikli, S., Demiroz, A.P., Ozkul, A., Antibody responses and viral load in patients with Crimean-Congo hemorrhagic fever: a comprehensive analysis during the early stages of the infection. Diagn. Microbiol. Infect. Dis. 79:1 (2014), 31–36.
12. Gozel, M.G., Bakir, M., Oztop, A.Y., Engin, A., Dokmetas, I., Elaldi, N., Investigation of Crimean-Congo hemorrhagic fever virus transmission from patients to relatives: a prospective contact tracing study. Am. J. Trop. Med. Hyg. 90:1 (2014), 160–162.
13. Hasanoglu, I., Guner, R., Carhan, A., Kocak Tufan, Z., Yagci-Caglayik, D., Guven, T., Yilmaz, G.R., Tasyaran, M.A., Crucial parameter of the outcome in Crimean Congo hemorrhagic fever: viral load. J. Clin. Virol. 75 (2016), 42–46.
14. Izadi, S., Salehi, M., Holakouie-Naieni, K., Chinikar, S., The risk of transmission of Crimean-Congo hemorrhagic fever virus from human cases to first-degree relatives. Jpn. J. Infect. Dis. 61:6 (2008), 494–496.
15. Karti, S.S., Odabasi, Z., Korten, V., Yilmaz, M., Sonmez, M., Caylan, R., Akdogan, E., Eren, N., Koksal, I., Ovali, E., Erickson, B.R., Vincent, M.J., Nichol, S.T., Comer, J.A., Rollin, P.E., Ksiazek, T.G., Crimean-Congo hemorrhagic fever in Turkey. Emerg. Infect. Dis. 10:8 (2004), 1379–1384.
16. Kaya, S., Elaldi, N., Kubar, A., Gursoy, N., Yilmaz, M., Karakus, G., Gunes, T., Polat, Z., Gozel, M.G., Engin, A., Dokmetas, I., Bakir, M., Yilmaz, N., Sencan, M., Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-alpha, IL-6, IL-10, and IFN-gamma levels in patients with Crimean-Congo hemorrhagic fever. Bmc Infect. Dis., 14, 2014.
17. Koksal, I., Yilmaz, G., Aksoy, F., Erensoy, S., Aydin, H., The seroprevalance of Crimean-Congo haemorrhagic fever in people living in the same environment with Crimean-Congo haemorrhagic fever patients in an endemic region in Turkey. Epidemiol. Infect. 142:2 (2014), 239–245.
18. Leblebicioglu, H., Crimean-Congo haemorrhagic fever in Eurasia. Int. J. Antimicrob. Agents 36:1 (2010), S43–S46.
19. Leblebicioglu, H., Crimean-Congo Hemorrhagic Fever. UpToDate. M. a. Hirsch. Waltham, MA., UpToDate. 2015.
20. Leblebicioglu, H., Ozaras, R., Irmak, H., Sencan, I., Crimean-Congo hemorrhagic fever in Turkey: current status and future challenges. Antivir. Res. 126 (2016), 21–34.
21. Leblebicioglu, H., Ozaras, R., Sunbul, M., Crimean-Congo Hemorrhagic Fever: a neglected infectious diseases with potential nosocomial infection threat. Am. J. Infect. Control, 2016 (in press).
22. Leblebicioglu, H., Sunbul, M., Bodur, H., Ozaras, R., T. Crimean-Congo Haemorrhagic Fever Research Network. Discharge criteria for Crimean-Congo haemorrhagic fever in endemic areas. J. Infect. 72:4 (2016), 500–501.
23. Leblebicioglu, H., Sunbul, M., Guner, R., Bodur, H., Bulut, C., Duygu, F., Elaldi, N., Cicek Senturk, G., Ozkurt, Z., Yilmaz, G., Fletcher, T.E., Beeching, N.J., Healthcare-associated Crimean-Congo haemorrhagic fever in Turkey, 2002-2014: a multicentre retrospective cross-sectional study. Clin. Microbiol. Infect. 22(4):387 (2016), e381–384.
24. Mourya, D.T., Yadav, P.D., Shete, A.M., Gurav, Y.K., Raut, C.G., Jadi, R.S., Pawar, S.D., Nichol, S.T., Mishra, A.C., Detection, isolation and confirmation of Crimean-Congo hemorrhagic fever virus in human, ticks and animals in ahmadabad, India, 2010-2011. Plos Negl. Trop. Dis., 6(5), 2012.
25. O'Dempsey, T., Khan, S.H., Bausch, D.G., Rethinking the discharge policy for Ebola convalescents in an accelerating epidemic. Am. J. Trop. Med. Hyg. 92:2 (2015), 238–239.
26. Papa, A., Drosten, C., Bino, S., Papadimitriou, E., Panning, M., Velo, E., Kota, M., Harxhi, A., Antoniadis, A., Viral load and Crimean-Congo hemorrhagic fever [17]. Emerg. Infect. Dis. 13:5 (2007), 805–806.
27. Pshenichnaya, N.Y., Sydenko, I.S., Klinovaya, E.P., Romanova, E.B., Zhuravlev, A.S., Possible sexual transmission of Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. 45 (2016), 109–111.
28. Rodriguez-Morales, A.J., Bandeira, A.C., Franco-Paredes, C., The expanding spectrum of modes of transmission of Zika virus: a global concern. Ann. Clin. Microbiol. Antimicrob., 15, 2016, 13.
29. Rowe, A.K., Bertolli, J., Khan, A.S., Mukunu, R., Muyembe-Tamfum, J.J., Bressler, D., Williams, A.J., Peters, C.J., Rodriguez, L., Feldmann, H., Nichol, S.T., Rollin, P.E., Ksiazek, T.G., Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. J. Infect. Dis. 179:1 (1999), S28–S35.
30. Saksida, A., Duh, D., Wraber, B., Dedushaj, I., Ahmeti, S., Avšič-Županc, T., Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo hemorrhagic fever. Clin. Vaccine Immunol. 17:7 (2010), 1086–1093.
31. Sunbul, M., Leblebicioglu, H., Fletcher, T.E., Elaldi, N., Ozkurt, Z., Bastug, A., Yilmaz, G., Guner, R., Duygu, F., Beeching, N.J., Crimean-Congo haemorrhagic fever and secondary bacteraemia in Turkey. J. Infect. 71:5 (2015), 597–599.
32. Swanepoel, B., Crimean-Congo Haemorrhagic Fever. 2012, Department of Agriculture, Forestry and Fisheries, Pretoria, South Africa (South Africa).
33. Uyar, Y., Çarhan, A., Albayrak, N., Altaş, A.B., Evaluation of PCR and ELISA-IgM results in the laboratory diagnosis of Crimean-Congo haemorrhagic fever cases in 2008 in Turkey. Mikrobiyoloji Bul. 44:1 (2010), 57–64.
34. WHO, Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. New Edition, 2009, WHO, Geneva.
35. WHO, Clinical Management of Patients with Viral Hemorrhagic Fever. A Pocket Guide for the Front-line Health Workers. 2016, World Health Organization, Geneva (Geneva, World Health Organization).
36. Yilmaz, G.R., Buzgan, T., Irmak, H., Safran, A., Uzun, R., Cevik, M.A., Torunoglu, M.A., The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int. J. Infect. Dis. 13:3 (2009), 380–386.